 

CytoDyn, Inc. (OTC: CYDY)
Next Super Stock investor conference presentation 8/15/2019
 
		
					VANCOUVER, Washington, Feb. 06, 2020– CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that it […]
 
		
					Dr. Lalezari Will Now Provide a Key Leadership Role in Accelerating CytoDyn’s Clinical Trials with Leronlimab for Coronavirus (COVID-19) and Multiple Cancer Indications VANCOUVER, Washington, Mar 13, 2020 — VANCOUVER, Washington, March 13, 2020 (GLOBE […]
 
		
					Join today’s most successful investors and Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something went wrong. Join over 100,000 investors and business leaders worldwide. Discover the Next Super […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
